Literature DB >> 33274930

Antibodies That Engage the Hemagglutinin Receptor-Binding Site of Influenza B Viruses.

Goran Bajic1,2, Stephen C Harrison1,3.   

Abstract

We describe cross-reactive human antibodies recognizing influenza B viruses spanning nearly 80 years of antigenic drift. Structures show that they engage the receptor-binding site (RBS) of the viral hemagglutinin with strong similarities to their influenza A counterparts, despite structural differences between the RBS of influenza A and B. Our data show that these antibodies readily cross-react with both influenza B Victoria and Yamagata lineages. We also note that all antibodies are encoded by IGHV3-9/IGK1-33. Future research will provide insight into the prevalence of these antibodies in the human population.

Entities:  

Keywords:  B-cell memory; hemagglutinin; influenza vaccine

Mesh:

Substances:

Year:  2020        PMID: 33274930      PMCID: PMC8276581          DOI: 10.1021/acsinfecdis.0c00726

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  28 in total

1.  Highly conserved protective epitopes on influenza B viruses.

Authors:  Cyrille Dreyfus; Nick S Laursen; Ted Kwaks; David Zuijdgeest; Reza Khayat; Damian C Ekiert; Jeong Hyun Lee; Zoltan Metlagel; Miriam V Bujny; Mandy Jongeneelen; Remko van der Vlugt; Mohammed Lamrani; Hans J W M Korse; Eric Geelen; Özcan Sahin; Martijn Sieuwerts; Just P J Brakenhoff; Ronald Vogels; Olive T W Li; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Andrew B Ward; Ian A Wilson; Jaap Goudsmit; Robert H E Friesen
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

Review 2.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

3.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

4.  Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.

Authors:  M N Matrosovich; A S Gambaryan; A B Tuzikov; N E Byramova; L V Mochalova; A A Golbraikh; M D Shenderovich; J Finne; N V Bovin
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

5.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

6.  Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site.

Authors:  Aaron G Schmidt; Khoi T Do; Kevin R McCarthy; Thomas B Kepler; Hua-Xin Liao; M Anthony Moody; Barton F Haynes; Stephen C Harrison
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

7.  Viral receptor-binding site antibodies with diverse germline origins.

Authors:  Aaron G Schmidt; Matthew D Therkelsen; Shaun Stewart; Thomas B Kepler; Hua-Xin Liao; M Anthony Moody; Barton F Haynes; Stephen C Harrison
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

8.  Distribution of surface glycoproteins on influenza A virus determined by electron cryotomography.

Authors:  Sebastian Wasilewski; Lesley J Calder; Tim Grant; Peter B Rosenthal
Journal:  Vaccine       Date:  2012-10-10       Impact factor: 3.641

9.  Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.

Authors:  Kevin R McCarthy; Akiko Watanabe; Masayuki Kuraoka; Khoi T Do; Charles E McGee; Gregory D Sempowski; Thomas B Kepler; Aaron G Schmidt; Garnett Kelsoe; Stephen C Harrison
Journal:  Immunity       Date:  2018-01-16       Impact factor: 43.474

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  1 in total

1.  A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.

Authors:  Aaron J Schmitz; Jackson S Turner; Zhuoming Liu; Julian Q Zhou; Ishmael D Aziati; Rita E Chen; Astha Joshi; Traci L Bricker; Tamarand L Darling; Daniel C Adelsberg; Clara G Altomare; Wafaa B Alsoussi; James Brett Case; Laura A VanBlargan; Tingting Lei; Mahima Thapa; Fatima Amanat; Trushar Jeevan; Thomas Fabrizio; Jane A O'Halloran; Pei-Yong Shi; Rachel M Presti; Richard J Webby; Florian Krammer; Sean P J Whelan; Goran Bajic; Michael S Diamond; Adrianus C M Boon; Ali H Ellebedy
Journal:  Immunity       Date:  2021-08-17       Impact factor: 43.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.